To Evaluate Effects of AZD1446, Placebo and Donepezil in Patients With Alzheimer's Disease
Status:
Terminated
Trial end date:
2011-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate whether treatment with single and multiple oral
doses of AZD1446 for 1 week will have effect on Quantified Electroencephalography and
Event-Related Potentials in patients with Alzheimers Disease. The total treatment period is 9
weeks, divided into 5 equally long sub-periods of 7 days and 4 wash-out periods of 7 days
each.